
Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.

Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.

Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.

Late-breaking data show allegic children as young as 1-4 years old may have sustained benefit from daily peanut protein exposure.

An interview with a Children's Hospital Colorado investigator on new remote-monitoring research into children's adherence trends.

The adjusted allergy prevalence in recent years was 2.6% in infants who have been introduced to peanuts at 12 months.

New survey results depict unexpected burdens in long-haul patients, as well as continued issues following rehabilitation.

Common positive effects includes help with sleep, less pain, and calming influence.

An interview with a study author on new interpretations of biologic asthma benefit.

A discussion on continued research into the first regulated treatment for pediatric peanut allergy.

Treatment showed a similar effect on patients with and without baseline asthma.

All patients in the study who tested positive for COVID-19 suffered from mild or moderate symptoms.

Researchers explore further endpoints from the SINUS-24 and SINUS-52 trials.

In data presented at AAAAI 2021, researchers present new data from the LIBERTY ASTHMA QUEST trial.

Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.

CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.

Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.

The role of many in psychiatry has changed during the COVID-19 pandemic.

Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.

Personalized, daily self-reporting for patients could influence future therapeutic strategies.

Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.

A pair of researchers present plans to improve collaboration with other professionals in ADHD.

The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.

An ADHD coach can work on more goal-based plans for individuals with ADHD.

A study finds that secondhand smoking may have a greater negative impact on children than prenatal smoke exposure.

There is a high association between parents' concerns of autism spectrum disorder in their children and identified symptoms of ADHD.

There is currently no approved treatment for fragile X syndrome.

Current estimates indicate that non-adherence to stimulants is as high as 87%.

New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.

Though the correlation is concerning for at-risk groups, experts believe it could inform individualized psychiatric care during crises.

The APSARD study finds that most neuropsychological assessment scores did not differ significantly between both in-person and virtual visit modalities.